1st Quarter - Report

THE HEALTH EQUITY STRATEGIES GROUP, LLC for TRAVERE THERAPEUTICS

Firm
Client
Income
$16,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Rare kidney disease

LobbyistCovered position, as disclosed
BRITT EVELYN WEINSTOCK —

Contacted: HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

Rare kidney disease

LobbyistCovered position, as disclosed
BRITT EVELYN WEINSTOCK —

Contacted: HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Rare kidney disease

LobbyistCovered position, as disclosed
BRITT EVELYN WEINSTOCK —

Pharmacy PHA

Rare kidney disease

LobbyistCovered position, as disclosed
BRITT EVELYN WEINSTOCK —

Contacted: HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.